| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.8 |